The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020
by from Morbidity and Mortality Weekly Report (MMWR) on (#5BKKC)
This report describes the interim recommendation made by the Advisory Committee on Immunization Practices on December 12, 2020, for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged >=16 years.